List of Levitra drug patents
Levitra is owned by Bayer Hlthcare.
Levitra contains Vardenafil Hydrochloride.
Levitra has a total of 2 drug patents out of which 0 drug patents have expired.
Levitra was authorised for market use on 19 August, 2003.
Levitra is available in tablet;oral dosage forms.
Levitra can be used as treatement of erectiile dysfunction by administering a film-coated tablet.
The generics of Levitra are possible to be released after 23 July, 2027.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8841446 | BAYER HLTHCARE | Medicaments containing vardenafil hydrochloride trihydrate |
Jul, 2023
(24 days from now) | |
| US8273876 | BAYER HLTHCARE | Medicaments containing vardenafil hydrochloride trihydrate |
Jul, 2027
(4 years from now) | |
Drugs and Companies using VARDENAFIL HYDROCHLORIDE ingredient
Market Authorisation Date: 19 August, 2003
Treatment: Treatement of erectiile dysfunction by administering a film-coated tablet
Dosage: TABLET;ORAL
LEVITRA family patents
3
Korea, Republic of
3
Croatia
3
European Union
2
Canada
2
Slovenia
2
China
2
Japan
2
Denmark
2
Spain
2
Norway
2
United States
2
Portugal
2
Cyprus
1
Poland
1
Cuba
1
Philippines
1
Ukraine
1
Brazil
1
Hong Kong
1
Lithuania
1
Morocco
1
Germany
1
Hungary
1
Mexico
1
New Zealand
1
Australia
1
South Africa
1
Ecuador
1
Austria
1
Russia
1
Israel
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic